Cost-effectiveness analysis of suvorexant for the treatment of Japanese elderly patients with chronic insomnia in a virtual cohort

References

• Bonnet MH, Arand DL. 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995;18:581-8
   Google Scholar
• Buysse DJ, Angst J, Gamma A, et al. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 2008;31:473-80
   PubMed Web of Science ®Google Scholar
• Basta M, Chrousos GP, Vela-Bueno A, et al. Chronic insomnia and stress system. Sleep Med Clin 2007;2:279-91
   Google Scholar
• Pigeon WR, Perlis ML. Sleep homeostasis in primary insomnia. Sleep Med Rev 2006;10:247-54
   Google Scholar
• Daley M, Morin CM, LeBlanc M, et al. Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. Sleep Med 2009;10:427-38
   Google Scholar
• Sivertsen B, Overland S, Neckelmann D, et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol 2006;163:1018-24
   PubMed Web of Science ®Google Scholar
• Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007;30:263-73
   PubMed Web of Science ®Google Scholar
• Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154:1417-23
   PubMed Web of Science ®Google Scholar
• Roth T, Roehrs TA. Issues in the use of benzodiazepine therapy. J Clin Psychiatry 1992;53(Suppl):14-18
   PubMed Web of Science ®Google Scholar
• Nutt D. GABAA receptors: Subtypes, regional distribution, and function. J Clin Sleep Med 2006;2:S7-S11
   PubMed Web of Science ®Google Scholar
• Bambauer KZ, Sabin JE, Soumerai SB. The exclusion of benzodiazepine coverage in Medicare: simple steps for avoiding a public health crisis. Psychiatr Serv 2005;56:1143-6
   PubMed Web of Science ®Google Scholar
• Kollen BJ, van der Veen WJ, Groenhof F, et al. Discontinuation of reimbursement of benzodiazepines in the Netherlands: Does it make a difference? BMC Fam Pract 2012;13:111
   PubMed Web of Science ®Google Scholar
• Rat C, Penhouet G, Gaultier A, et al. Did the new French pay-for-performance system modify benzodiazepine prescribing practices? BMC Health Serv Res 2014;14:301
   PubMed Web of Science ®Google Scholar
• Clay E, Falissard B, Moore N, et al. Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries. Eur J Clin Pharmacol 2013;69:1-10
   PubMed Web of Science ®Google Scholar
• Nakao M, Takeuchi T, Yano E. Prescription of benzodiazepines and antidepressants to outpatients attending a Japanese university hospital. Int J Clin Pharmacol Ther 2007;45:30-5
   PubMed Web of Science ®Google Scholar
• Nakao M, Sato M, Nomura K, et al. Benzodiazepine prescription and length of hospital stay at a Japanese university hospital. Biopsychosoc Med 2009;3:10
   PubMedGoogle Scholar
• Kim K, Uchiyama M, Okawa M et al. An epidemiological study of insomnia among the Japanese general population. Sleep 2007;23:41-7
   Google Scholar
• Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331:1169
   PubMed Web of Science ®Google Scholar
• Herings RM, Stricker BH, de Boer A, et al. Benzodiazepines and the risk for falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 1995;155:1801-7
   PubMed Web of Science ®Google Scholar
• Shuto H, Imakyure O, Matsumoto J, et al. Medication use as a risk factor for inpatient falls in an acute care hospital: a case-crossover study. Br J Clin Pharmacol 2010;69:535-42
   PubMed Web of Science ®Google Scholar
• Cashin RP, Yang M. Medications prescribed and occurrence of falls in general medicine inpatients. Can J Hosp Pharm 2011;64:321-6
   PubMedGoogle Scholar
• Allain H, Bentue-Ferrer D, Polard E, et al. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging 2005;22:749-65
   PubMed Web of Science ®Google Scholar
• Allain H, Bentue-Ferrer D, Tarral A, et al. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo. Eur J Clin Pharmacol 2003;59:179-88
   PubMed Web of Science ®Google Scholar
• Frels C, Williams P, Narayanan S, et al. Iatrogenic causes of falls in hospitalised elderly patients: a case-control study. Postgrad Med J 2002;78:487-9
   PubMed Web of Science ®Google Scholar
• Pierfitte C, Macouillard G, Thicoipe M, et al. Benzodiazepines and hip fractures in elderly people: case-control study. BMJ 2001;322:704-8
   PubMed Web of Science ®Google Scholar
• Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989;262:3303-7
   PubMed Web of Science ®Google Scholar
• Wang PS, Bohn RL, Glynn RJ, et al. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 2001;49:1685-90
   PubMed Web of Science ®Google Scholar
• Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-85
   PubMed Web of Science ®Google Scholar
• de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998;95:322-7
   PubMed Web of Science ®Google Scholar
• Gotter AL, Webber AL, Coleman PJ, et al. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacology. Pharmacol Rev 2012;64:389-420
   Google Scholar
• Herring WJ, Connor KM, Ivgy-May N, et al. Suvorexant in patients with insomnia: Results from two 3-month randomized controlled clinical trials. Biol Psychiatry 2016;79:136-48.
   PubMed Web of Science ®Google Scholar
• BELSOMRA Japanese prescribing information (in Japanese). Available at: http://www.info.pmda.go.jp/go/pack/1190023F1024_1_09/. Accessed January 23, 2018.
   Google Scholar
• Herring WJ, Connor KM, Snyder E, et al. Suvorexant in elderly patients with insomnia: pooled analyses of data from phase III randomized controlled clinical trials. Am J Geriatr Psychiatry 2017;25:791-802
   PubMed Web of Science ®Google Scholar
• Ong MK, Zhang L, Xu H, et al. Medicare part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders. Psychiatr Serv 2012;63:637-42
   PubMed Web of Science ®Google Scholar
• Ong MK, Xu H, Zhang L, et al. Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users. J Am Geriatr Soc 2012;60:1292-7
   PubMed Web of Science ®Google Scholar
• Takeshima N, Ogawa Y, Hayasaka Y, et al. Continuation and discontinuation of benzodiazepine prescriptions: a cohort study based on a large claims database in Japan. Psychiatry Res 2016;237:201-7
   PubMed Web of Science ®Google Scholar
• Finkle WD, Der JS, Greenland S, et al. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 2011;59:1883-90
   PubMed Web of Science ®Google Scholar
• Huedo-Medina TB, Kirsch I, Middlemass J, et al. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: Meta-analysis of data submitted to the Food and Drug Administration. BMJ 2012;345:e8343
   PubMed Web of Science ®Google Scholar
• Citrome L. Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic–what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract 2014;68:1429-41
   PubMed Web of Science ®Google Scholar
• Asai Y, Miyazaki M, Iwakura M, et al. Post-marketing surveillance of Suvorexant (BELSOMRA Tablets 15 mg, 20 mg) (interim report). Jpn J Sleep Med 2017;11:249-63 (in Japanese)
   Google Scholar
• Sogabe K, Yoshiyasu T, Sou M. Efficacy and safety of zolpidem (MYSLEE tablets) a subsequent report of the post-marketing surveillance. J New Rem Clin 2012;61:2279-94 (in Japanese)
   Google Scholar
• Botteman MF, Ozminkowski RJ, Wang S, et al. Cost-effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model. CNS Drugs 2007;21:319-34
   PubMed Web of Science ®Google Scholar
• Lin FY, Chen PC, Liao CH, et al. Retrospective population cohort study on hip fracture risk associated with zolpidem medication. Sleep 2014;37:673-9
   PubMed Web of Science ®Google Scholar
• Hagino H, Nakamura T, Fujiwara S, et al. Sequential change in quality of life for patients with incident clinical fractures: a prospective study. Osteoporos Int 2009;20:695-702
   PubMed Web of Science ®Google Scholar
• Yasumura S, Kanari Y. TENTOU NO EKIGAKU. [Epidemiology of falling.] Clin Calcium 2003;13:1010-14 (in Japanese)
   PubMedGoogle Scholar
• Park SM, Ryu J, Lee DR, et al. Zolpidem use and risk for fractures: a systematic review and meta-analysis. Osteoporos Int 2016;27:2935-44
   PubMed Web of Science ®Google Scholar
• Japan Ministry of Health, Labour, and Welfare. Medical fee schedule, Japanese. Tokyo, Japan. Available at: http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000106421.html. Accessed July 14, 2017
   Google Scholar
• Mori T, Crandall CJ, Ganz DA. Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan. Osteoporos Int 2017;28:1733-44
   PubMed Web of Science ®Google Scholar
• Avidan AY, Fries BE, James ML, et al. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005;53:955-62
   PubMed Web of Science ®Google Scholar
• International Narcotics Control Board. Report of the International Narcotics Control Board on the Availability of Internationally Controlled Drugs: ensuring adequate access for medical and scientific purposes. 2010. Available at: http://apps.who.int/medicinedocs/en/m/abstract/Js21969en/
   Google Scholar